Quantum量子訊息有限公司
← 最新全球產業報告

Heart Valve Devices Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-01-23　·　168 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模
USD 15.70 Bn
2033 年預估規模
USD 31.90 Bn
年複合成長率 CAGR
10.7%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights產業別 Medical Devices出版日期 2026-01-23頁數 168報告編號 CMI9252

授權報價

Single User Price$4,500 USD
Enterprise License$10,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
Heart Valve Devices Market, By Device Type (Surgical Heart Valves , Transcatheter Heart Valves , Valve Repair Devices), By Valve Position (Aortic Valve Devices , Mitral Valve Devices , Tricuspid Valve Devices- , and Pulmonary Valve Devices), By Product Category (Mechanical Valves , Bioprosthetic Tissue Valves , and Polymer Valves), By End User (Hospitals, Cardiac Specialty Centers, and Ambulatory Surgical Centers), By Age Group (Pediatric, Adult, and Geriatric), By Distribution Channel (Online and Offline), By Indication (Aortic Stenosis , Mitral Regurgitation , Tricuspid Regurgitation , Pulmonary Valve Dysfunction , and Mixed Valve Disease), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

報告摘要

According to Coherent Market Insights, the global heart valve devices market is estimated to be valued at USD 15.70 Bn in 2026 and is expected to reach USD 31.90 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 10.7% from 2026 to 2033. The global heart valve devices market represents a critical segment within the cardiovascular medical device industry, addressing the growing prevalence of valvular heart diseases worldwide. Heart valve devices encompass a comprehensive range of therapeutic solutions including mechanical valves, biological valves, transcatheter heart valves, and valve repair devices designed to restore proper cardiac function in patients with compromised valve performance. The market has experienced significant transformation driven by technological advancements in minimally invasive procedures, particularly transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR) technologies. Rising geriatric population, increasing incidence of rheumatic heart disease, congenital heart defects, and lifestyle-related cardiovascular conditions have substantially expanded the patient pool requiring valve interventions. The industry has witnessed remarkable innovation in biocompatible materials, valve durability, and procedural techniques, enabling improved patient outcomes and reduced recovery times. Regulatory approvals for next-generation valve technologies and expanding indications for transcatheter procedures have further accelerated market growth. The convergence of advanced imaging technologies, artificial intelligence, and precision medicine approaches continues to reshape treatment paradigms, making heart valve interventions more accessible and effective across diverse patient populations globally. Market Dynamics The global heart valve devices market is propelled by several key drivers, including the rapidly aging global population which inherently increases the prevalence of age-related valvular diseases such as aortic stenosis and mitral regurgitation. Technological breakthroughs in transcatheter valve technologies have revolutionized treatment approaches, offering less invasive alternatives to traditional open-heart surgery, thereby expanding treatment accessibility to high-risk and inoperable patients previously deemed unsuitable for intervention. Rising awareness about cardiovascular health, improved diagnostic capabilities, and enhanced healthcare infrastructure in emerging markets further drive market expansion. Additionally, increasing adoption of minimally invasive procedures, favorable reimbursement policies, and growing physician expertise in transcatheter techniques contribute significantly to market growth. However, the market faces notable restraints including the high cost of advanced valve devices and associated procedures, which limits accessibility in cost-sensitive markets and healthcare systems with budget constraints. Stringent regulatory approval processes for new devices create lengthy development timelines and substantial investment requirements, potentially deterring smaller manufacturers from market entry. Technical complications associated with valve procedures, limited long-term durability data for newer transcatheter devices, and the need for specialized training programs for healthcare professionals pose additional challenges. Despite these constraints, substantial opportunities exist in emerging markets with improving healthcare infrastructure, development of cost-effective valve solutions for broader patient access, expansion of treatment indications for transcatheter procedures, integration of digital health technologies for improved patient monitoring, and potential applications in pediatric populations where significant unmet medical needs persist. Key Features of the Study • This report provides in-depth analysis of the global heart valve devices market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global heart valve devices market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, LivaNova, Artivion, JenaValve Technology, JC Medical, Meril Life Sciences, Venus Medtech, MicroPort CardioFlow Medtech, Peijia Medical, Lepu Medical Technology, Braile Biomédica, and Anteris Technologies • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global heart valve devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global heart valve devices market Market Segmentation • Device Type Insights (Revenue, USD Bn, 2021 - 2033) o Surgical Heart Valves o Transcatheter Heart Valves o Valve Repair Devices • Valve Position Insights (Revenue, USD Bn, 2021 - 2033) o Aortic Valve Devices o Mitral Valve Devices o Tricuspid Valve Devices o Pulmonary Valve Devices • Product Category Insights (Revenue, USD Bn, 2021 - 2033) o Mechanical Valves o Bioprosthetic Tissue Valves o Polymer Valves • End User Insights (Revenue, USD Bn, 2021 - 2033) o Hospitals o Cardiac Specialty Centers o Ambulatory Surgical Centers • Age Group Insights (Revenue, USD Bn, 2021 - 2033) o Pediatric o Adult o Geriatric • Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033) o Online o Offline • Indication Insights (Revenue, USD Bn, 2021 - 2033) o Aortic Stenosis o Mitral Regurgitation o Tricuspid Regurgitation o Pulmonary Valve Dysfunction o Mixed Valve Disease • Regional Insights (Revenue, USD Bn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Edwards Lifesciences o Medtronic o Abbott o Boston Scientific o LivaNova o Artivion o JenaValve Technology o JC Medical o Meril Life Sciences o Venus Medtech o MicroPort CardioFlow Medtech o Peijia Medical o Lepu Medical Technology o Braile Biomédica o Anteris Technologies
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Heart Valve Devices Market, By Device Type  Global Heart Valve Devices Market, By Valve Position  Global Heart Valve Devices Market, By Product Category  Global Heart Valve Devices Market, By End User  Global Heart Valve Devices Market, By Age Group  Global Heart Valve Devices Market, By Distribution Channel  Global Heart Valve Devices Market, By Indication  Global Heart Valve Devices Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Key Developments o Industry Trends 4. Global Heart Valve Devices Market, By Device Type, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Surgical Heart Valves  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Transcatheter Heart Valves  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Valve Repair Devices  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 5. Global Heart Valve Devices Market, By Valve Position, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Aortic Valve Devices  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Mitral Valve Devices  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Tricuspid Valve Devices-  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Pulmonary Valve Devices  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 6. Global Heart Valve Devices Market, By Product Category, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Mechanical Valves  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Bioprosthetic Tissue Valves  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Polymer Valves  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 7. Global Heart Valve Devices Market, By End User, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Hospitals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Cardiac Specialty Centers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Ambulatory Surgical Centers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 8. Global Heart Valve Devices Market, By Age Group, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Pediatric  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Adult  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Geriatric  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 9. Global Heart Valve Devices Market, By Distribution Channel, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Online  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Offline  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 10. Global Heart Valve Devices Market, By Indication, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Aortic Stenosis  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Mitral Regurgitation  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Tricuspid Regurgitation  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Pulmonary Valve Dysfunction  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Mixed Valve Disease  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 11. Global Heart Valve Devices Market, By Region, 2021 - 2033, Value (USD Bn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Valve Position, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Product Category, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Valve Position, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Product Category, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Valve Position, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Product Category, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Valve Position, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Product Category, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Valve Position, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Product Category, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Valve Position, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Product Category, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn) o South Africa o North Africa o Central Africa 12. Competitive Landscape o Edwards Lifesciences  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Medtronic  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Abbott  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Boston Scientific  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o LivaNova  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Artivion  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o JenaValve Technology  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o JC Medical  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Meril Life Sciences  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Venus Medtech  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o MicroPort CardioFlow Medtech  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Peijia Medical  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Lepu Medical Technology  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Braile Biomédica  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Anteris Technologies  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 13. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 14. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on 'Heart Valve Devices Market' - Global forecast to 2033

提及公司

Edwards LifesciencesMedtronicAbbottBoston ScientificLivaNovaArtivionJenaValve TechnologyJC MedicalMeril Life SciencesVenus MedtechMicroPort CardioFlow MedtechPeijia MedicalLepu Medical TechnologyBraile BiomédicaAnteris Technologies

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們